AI assistant
Sending…
AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2013
Jul 23, 2013
31580_dirs_2013-07-23_d7252472-a477-40e7-847a-d973efee61e8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2013-07-23
Reporting Person: Cole Douglas G. (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| No securities are beneficially owned | 0 | Direct |
Footnotes
F1: Mr. Cole does not own shares in his individual capacity. He is a member of Flagship Ventures 2007 General Partner LLC, the sole general partner of Flagship Ventures Fund 2007 L.P. (the "Fund"). The Fund is a reporting person and has filed a Form 3 reporting its ownership. Mr. Cole disclaims beneficial ownership of the Fund's shares, except to the extent of his pecuniary interest therein.
More from AGIOS PHARMACEUTICALS, INC.
Interim / Quarterly Report
2026
Apr 29
Earnings Release
2026
Apr 29
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3